The sector started the week looking like it might break under the range but has ended the week threatening to break out above the range. All that being said I strongly suspect that the outcome is that we once again remain in the range. At some point the range will fail but trying to time […]
June 11th Biotech Update
Still not a lot to talk about but the market is starting to feel heavy. That being said we remain rangebound in the sector. Sure we are getting these swings and significant red days but we still are basically trading sideways. This is not true for the broader market that seems more like a top […]
May 21st Biotech (and MLP) Update
The past two weeks or so has seen some large moves on a daily basis and yet there has basically been very little movement in the sector (or market writ large). There seems to be a continued bull versus bear debate ongoing in the market and the basic outlines (if you have seen these articles) […]
May 19th Biotech Update
What kills bulls runs in the sector? News can but the floodgate of secondaries opening is also a sure why these end. Yesterday saw the opening of the secondary window and while the first wave of secondaries does not always kill bull runs, it seems like we are at the beginning of the end. We […]
May 15th Biotech Update
It seems a fight/indecision in the sector right now. It remains right at the breakout level unable to move higher to confirm the breakout or move lower to reinforce the level as resistance. It still seems to be doing modestly better than the broader markets but there seems clear indecision at this level and at […]
May 11th Biotech Update
We were able to break above resistance last Friday but could not quite close above it and did not get the run on the breakout. This morning the sector is slightly weak as is the general market. It will be a real test of the sector as there is little news to drive it higher […]
May 7th Biotech Update
Earnings continue and the themes are basically the same. They are generally good if not better than expectations but they remain cautious for the rest of the year. The sector is certainly rebounding from the selling late last week but there seems to be this odd late day selling despite strength during most of the […]
May the Force Be With Biotech Update
The trend is you friend until it is not anymore. We had a nice strong uptrend that appears to have broken. This obviously does not mean that we are moving to the low but that the next direction is not precisely clear. We needed to digest that recent move as it was almost straight up […]
May 1st Biotech Update
We finally get two days in a row of the same move but unfortunately it is down. This is not completely surprising as it is completely reasonable that the sharp move higher in the market needs to pause and/or retrench a little. Of course, the tension and worry will be whether or not this is […]
March 17 Biotech Update
Do we get our turn around Tuesday? Timing is about right in terms of the oversold conditions and that they are almost historically oversold. A true dead cat bounce would be absolutely epic in the short squeeze. I am not talk a couple of percent or even 5%. When the bounce happens it should be […]
February 7th Biotech Update
The sector seems to be in an odd spot. Fundamentals look fine and the trading is not awful but the chart looks precarious. We might have 3 lower highs and 3 lower lows right now. It almost looks like a broadening top but that usually sees higher highs as well as lower lowers. The chart […]
January 27 Biotech Update
We are heading into a perfect storm for weakness, so stay nimble and/or hedged. The sector has had a nice run and was overbought. We had an uneventful JPM and are set for a series of post-JPM secondaries. The broader market is going to be weak given growing pandemic fears (and the real impact it […]
January 13 Biotech Update
It looks like JPM is going to be a dud. The only deal announced so far with the smallish LLY deal for DERM last week. This has to be one of the weakest news JPM I remember. Add the lack of news with Bernie Sanders recent spike in the political polls and this does not […]
August 29th Biotech Update
I will keep this short and sweet as there is little news to talk about. On the positive side, the sector seems to be doing better and while I would not call it a false breakdown yet, the possibility remains. Clearly we need a continuation rally but we got exactly what we needed yesterday. Today […]
August 16th Biotech Update
So far the week is ending on a positive note but it is early but not surprising that we see some sort of bounce in the market. I sort of wonder how the trading ends the day as it will send a stronger signal than how trading starts. We have seen a lot of macro […]
June 27 Biotech Update
A good start to the morning for the sector, although it seems mostly in line with the broader markets. Given the performance the past couple days, however, I am happy to see it up with the broader markets, especially given that lack of any real news (although we are still potentially in the glow of […]
June 25 Biotech Update
So that was unexpected. First, the market is down and sector is higher. Second, we got another large merger to digest. Obviously I will focus on the deal and its implications. 1. I need to go back and listen the conference call so there might be some additional insight later this week but this deal […]
May 14 Biotech Update
I am not sure who had a more difficult day yesterday. You all for having to watch another market meltdown over China fears (and others) or me who had to help chaperone a middle school trip to New Orleans. In any case, we have all survived and the market seems to be bouncing this morning. […]
April 25th Biotech Update
Yesterday really ended up offering no real direction. We could not quite rally but we also did not quite collapse. Everything that I talked about yesterday about the trading of the sector also applies today given the lack of clarity. I do think it is telling that these large cap earnings are basically being greeted […]
January 25 Biotech Update
Another day and another lackluster pharma earnings. In some sense, it is good to see this have limited impact on the sector but on the other hand this is certainly not a bullish fundamental situation to see growth slowing in pharma. Clearly next week will be more important as we get into the large cap […]
